IL22 and Hepatitis: In many of these experimental models, such as conA-mediated hepatitis, IL-22-deficient mice are extremely more susceptible than are wild-type controls, with highly elevated aspartate transaminase (AST) and alanine transaminase (ALT) levels and large regions of necrotic tissue (48).